Press Releases

miR Scientific presents breakthrough new data on the miR Scientific Sentinel™ tests for the detection and classification of prostate cancer in urinary exosomes

exosomes

Dr. Laurence Klotz M.D., FRCSC, CM, the Chief Medical Officer of miR Scientific LLC, presents the results of the recently completed Case-Control validation study of 1,436 patients consisting of 836 patients in a fully cross-validated training group and independent testing group of ...

Read More »

Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment

exosomes

A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment...

Read More »